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Abstract
Background: Candida parapsilosis is one of the most common causes of Candida infection worldwide. However,
the genome sequence annotation was made without experimental validation and little is known about the
transcriptional landscape. The transcriptional response of C. parapsilosis to hypoxic (low oxygen) conditions, such as
those encountered in the host, is also relatively unexplored.
Results: We used next generation sequencing (RNA-seq) to determine the transcriptional profile of C. parapsilosis
growing in several conditions including different media, temperatures and oxygen concentrations. We identified
395 novel protein-coding sequences that had not previously been annotated. We removed > 300 unsupported
gene models, and corrected approximately 900. We mapped the 5’ and 3’ UTR for thousands of genes. We also
identified 422 introns, including two introns in the 3’ UTR of one gene. This is the first report of 3’ UTR introns in
the Saccharomycotina. Comparing the introns in coding sequences with other species shows that small numbers
have been gained and lost throughout evolution. Our analysis also identified a number of novel transcriptional
active regions (nTARs). We used both RNA-seq and microarray analysis to determine the transcriptional profile of
cells grown in normoxic and hypoxic conditions in rich media, and we showed that there was a high correlation
between the approaches. We also generated a knockout of the UPC2 transcriptional regulator, and we found that
similar to C. albicans, Upc2 is required for conferring resistance to azole drugs, and for regulation of expression of
the ergosterol pathway in hypoxia.
Conclusion: We provide the first detailed annotation of the C. parapsilosis genome, based on gene predictions
and transcriptional analysis. We identified a number of novel ORFs and other transcribed regions, and detected
transcripts from approximately 90% of the annotated protein coding genes. We found that the transcription factor
Upc2 role has a conserved role as a major regulator of the hypoxic response in C. parapsilosis and C. albicans.
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Background
Candida species are the causative agents of 8-10% of
hospital-acquired bloodstream infections worldwide [1].
Candida albicans remains the most common, but other
species (such as Candida tropicalis, Candida parapsilo-
sis and Candida glabrata) are increasing in frequency.
C. parapsilosis is currently the second most commonly
isolated species in Latin America, and it is particularly
prevalent in children less than 1 year old [2]. C. parapsi-
losis is also a frequent cause of infection in Europe [2].
Pathogenesis of C. parapsilosis is associated with use of
indwelling medical devices and with high glucose feeds
[3]. This species is often found on the hands of health
care workers, and has been responsible for several out-
break infections [4-9].
Until recently, C. parapsilosis isolates were believed to
be highly heterogeneous, and were divided into Groups I,
II and III [10,11]. Group I isolates are now defined as C.
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any medium, provided the original work is properly cited.parapsilosis, whereas Groups II and III have been redesig-
nated as the closely related species C. orthopsilosis and C.
metapsilosis [12]. C. parapsilosis Group I isolates are very
homogeneous, and are very difficult to distinguish using
standard molecular methods such as RAPD profiling
[13,14]. Sequencing the C. parapsilosis genome revealed
that there are very few differences between the diploid
chromosomes, with only one single nucleotide polymorph-
ism (SNP) per 15,553 bases [15]. This may indicate that
the species has undergone a recent population bottleneck,
perhaps related to the lack of a sexual cycle, and the loss
of one mating type [15-17].
The C. parapsilosis genome was sequenced in 2009,
together with the genomes of 5 other Candida species
[15]. There are currently two independent annotations of
the genome. One was generated from an early assembly
(consisting of 143 contigs) using an automated annota-
tion pipeline and contains 5733 gene models, which are
identified with the prefix “cpag” ([15]http://www.broad.
mit.edu/annotation/genome/candida_group/MultiHome.
html). A second annotation produced by our laboratory
using the same assembly characterized 5,834 gene models
(including 12 mitochondrial genes), which are identified
with the prefix “cpar” [18,19]. The initial annotations
proved useful for large-scale comparative analysis [15,19]
and for the design and application of transcriptional pro-
filing [18,20]. However, neither the “cpag” nor “cpar”
annotations included predictions of introns in any genes.
Moreover, the genome sequence was also subsequently
improved so that most of the current assembly consists
of 8 contigs, corresponding to complete chromosomes
[15]. We have now used this assembly as the basis for a
new annotation of the C. parapsilosis genome.
We applied next-generation sequencing to explore and
better define the transcriptional landscape. More than 330
million Illumina reads were generated from seven different
growth conditions (including varying temperatures, media
and oxygen levels). Strand-specific and long read libraries
were included in the experimental design. We used these
data to refine gene models, determine intron boundaries,
identify nTARs and eliminate overlapping gene models
lacking transcriptional support. We also used both RNA-
seq and microarray analysis to determine the transcrip-
tional response of C. parapsilosis to growth on rich media
in hypoxic conditions, and we found a high correlation
between the two approaches. Finally, we used transcrip-
tional profiling to investigate the role of the Upc2 tran-
scription factor as a regulator of the hypoxic response.
Results and discussion
Determining the transcriptional profile of Candida
parapsilosis
Next-generation sequencing (Illumina) was used to
determine the transcriptome of C. parapsilosis,a n dt o
annotate the genome. In order to maximize coverage,
we generated libraries from several conditions, including
varied temperature (30°C, 37°C), media (YPD, YPgly-
cerol, BMW, SD) and oxygen levels (21% and 1% O2)
(Additional file 1). BMW media is designed to minimize
growth differences between different species [21].
Strand-specific libraries were prepared from some sam-
ples grown in normoxia and hypoxia, and for a wildtype
strain and a strain carrying a knockout of an ortholog of
the Candida albicans UPC2 transcription factor, a
major regulator of ergosterol synthesis and the hypoxic
response [22-24]. Most reads were approximately 36
bases long; two long read (78 base) libraries were also
generated commercially, from cells grown in YPD at 30°
C. Approximately 280 million reads (including 26 mil-
lion reads from the rDNA locus) were mapped to single
locations in the genome using TopHat [25].
We produced a new annotation (Cpar2 prefix) by
combining the RNA-seq data with the existing (cpag
and cpar) annotations of the C. parapsilosis genome
[15,18] and visualizing using the Artemis browser [26]
(Figure 1). We identified 395 novel gene models (includ-
ing 120 with introns) that were not included in the cpag
annotation described in Butler et al [15,18] (Table 1,
Table 2). We removed 318 overlapping gene models,
and we corrected 664 by altering the position of start
and stop codons, removing in-frame stop codons or
identifying internal introns (Table 2). We also identified
26 pseudogenes that are well conserved with other Can-
dida species, but the reading frames are interrupted by
stop codons. In total, the Cpar2 annotation includes
5810 protein-coding genes and 91 potential tRNA genes
that were predicted using tRNAscan-SE [27] (Table 1).
We detected expression (FPKM, fragments per kilobase
of transcript per million fragments mapped, value higher
than 10) of 94% of the total protein-coding genes in the
Cpar2 annotation.
To identify the boundaries of the 5’ and 3’ untrans-
lated regions (UTRs) we looked for continuous read
coverage (> 2 reads) that extended beyond the open
reading frames. It was not always possible to correctly
establish the UTR boundary, particularly where inter-
genic regions are small. Where possible, strand specific
data was used to differentiate the UTRs of genes that
are on opposite strands. We identified 5’ UTRs for 4682
gene models, plus an additional 834 gene models where
the predicted UTR overlaps with a neighboring anno-
tated feature (Additional file 2). For 295 5’ UTRs and
195 3’ UTRs, the expression level was not high enough
to analyze. Genes with long 5’ UTRs (> 500 bp; 295
gene models) are enriched for regulatory GO processes
(Additional file 3) suggesting that there is a correlation
between long UTR regions and regulatory function. This
has also been reported in C. albicans [28]. We identified
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Page 2 of 143532 3’ UTRs, of which 135 are longer than 500 bp.
These are not enriched for any GO term. We were
unable to define the 3’ UTR for 2080 gene models
because they overlapped with the UTR or coding region
of the neighboring gene.
Intron Discovery
One of the main advantages of RNA-seq is that it can
be used to characterize introns. TopHat [25] identifies
reads that overlap a splice junction, and aligns them to
either side of a canonical splice site. We manually
curated each candidate predicted by TopHat by examin-
ing the overall read coverage, verifying the presence of
canonical (GT/AG) splice sites, and comparing to
orthologous genes from closely related species. We
found RNA-seq evidence supporting 368 novel introns,
many in open reading frames not described in the cpag
and cpar annotations. Most of the introns (70%) were
identified from 13.8 million reads of 78 base pairs
(Additional file 1); the longer reads were considerably
more useful than the shorter ones. To identify introns
i ng e n e st h a ta r en o te x p r e s s e di nt h ec o n d i t i o n sw e
used, we compared the C. parapsilosis genome to gene
models predicted in C. albicans [28-31]. We identified
an additional 55 introns that are conserved between C.
albicans and C. parapsilosis.
Our final annotation includes a total of 422 introns in
387 genes (Additional file 4). Whereas most lie within
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Figure 1 Annotation of the C. parapsilosis genome. (A) Mapping of reads to a region of chromosome 2 (Contig005809). In the top panel, the
transcribed strand is not identified. Strand-specific libraries shown below easily distinguish between the adjacent genes Cpar2_205910 and
Cpar2_205920. Cpar2_205880 is expressed at a higher level than the other genes in the region. It also contains a short intron. (Data is from YPD
media at 30°C for both strand-specific and non-specific information, from different experiments). (B) Gene with multiple introns (Cpar2_602860).
This is an ortholog of orf19.4193 in C. albicans, which also has 3 introns at equivalent positions. Intronic regions in C. parapsilosis are well defined
by an abrupt drop in the coverage abundance. (C) Identification of a novel transcriptional active region (nTAR). Transcribed regions not
associated with annotated features were designated as nTARs. One potential example, which is a homolog of the U14 small nucleolar RNA from
S. cerevisiae (snR128), is indicated with a bracket.
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Page 3 of 14coding sequences, 34 introns are located in 5’ UTRs,
and there are two in 3’ UTRs. We selected a sample of
eight gene models for validation by RT-PCR: one with
two 3’UTR introns, two with introns in the 5’ UTR, and
five with introns within the coding region (Figure 2).
The selected genes included orthologs of four that are
known to contain introns in C. albicans, which are con-
served in C. parapsilosis (Figure 2, Additional file 5).
The C. parapsilosis orthologs of RPL20 (Cpar2_400980)
and RPS29A (Cpar2_205880) contain introns in the
5’UTR regions that are spliced during growth on YPD
( F i g u r e2 ) .T h e s ea r en o ta n n o t a t e di nC. albicans.I n
addition, orf19.114 has no annotated intron in C. albi-
cans,b u ti t sC. parapsilosis ortholog (Cpar2_603230)
contains an intron in the coding sequence. It is possible
that many of these differences are due to errors in anno-
tation in C. albicans.
The two 3’ UTR introns we identified by RNA-seq are
both in the same gene, Cpar2_601470. We confirmed
both by RT-PCR (Figure 2). Cpar2_601470 is an
ortholog of C. albicans orf19.3481 (gene of unknown
function), which has no known introns. Although 3’
UTR introns have been reported in animals and plants
[32] and in fungi such as Cryptococcus [33], no 3’ UTR
introns have been identified previously in Candida or
Saccharomyces species. Introns in 3’ UTRs are assumed
to be rare because structures after stop codons are likely
to subject the mRNA to nonsense-mediated decay [33].
The 3’ exons in Cpar2_601470 are transcribed at a
much lower level than the reading frame (Figure 2A),
and unspliced as well as spliced products are present
(Figure 2B). It is therefore possible that the 3’ UTR
introns are important for the regulation of expression of
this gene.
The total numbers of introns are similar in C. albicans
(431 introns in 387 genes [34]) and C. parapsilosis (422
introns in 387 genes). The 5’ and 3’ splice site consensus
are also very similar (Additional file 6). However, the
median length is smaller in C. parapsilosis (68 bp) than
in C. albicans (84 bp) (Additional file 6). For many
other Candida species, the genome annotations are not
accurate enough to compare intron locations. Any com-
parative analysis is therefore restricted to genomes were
introns have been predicted, or experimentally identi-
fied. For example, in C. albicans introns have been care-
fully validated using both experimental and predictive
methods [28-31]. The genome annotations of C. dubli-
niensis and Debaryomyces hansenii also include predic-
tions of a significant numbers of introns [35,36]. We
therefore compared the intronic landscape of these
three species with C. parapsilosis.O r t h o l o g o u sg e n e s
were identified using the Candida Gene Order Browser
[19].
We found that among 4869 orthologous genes present
in all four species, 425 have introns in at least one spe-
cies (466 introns in total, as some genes have more than
one intron) (Additional file 7). We attempted to identify
introns that were gained or lost in individual species
using the approach described in Zhang et al [37] (Figure
3 ) .A ni n t r o nw a ss c o r e da sa“gain” if it was present in
only one Candida species (or lineage) (Additional file
7 ) .A ni n t r o ni sa s s u m e dt ob e“lost” if it is present in
most of the species, and missing in either a single spe-
cies or a single lineage. We could not determine the
evolutionary origin of most introns (247), which are
conserved in all the species tested. Other cases were
ambiguous, for example introns present in only the
orthologs from C. dubliniensis and D. hansenii,c o u l d
represent independent gains in these species, or inde-
pendent losses in the others. Where possible we
included outgroups such as Saccharomyces cerevisiae
and Pichia pastoris [38-40] to evaluate potential intron
gains. Overall, we identified at least 30 cases of intron
gain, and 70 cases of intron loss. We identified 68
Table 1 Details of the Cpar2 annotation of the C.
parapsilosis genome
Protein coding genes
Single-exon gene models 5423
Multi-exon gene models:
Genes with introns in CDS only
1 353
Genes with introns in UTR 34
Total protein coding genes 5810
Pseudogenes 26
Total protein-coding genes and pseudogenes 5836
tRNA genes 91
rRNA genes 4
nTARs 95
Genes with mapped 5’ UTRs 4682
Genes with overlapping 5’ UTRs 834
Genes with mapped 3’ UTRs 3532
Genes with overlapping 3’ UTRs 2087
1Two genes have introns in both 5’UTR and CDS sequence.
Table 2 Comparison of protein-coding predictions in the
cpar and cpag annotations to the Cpar2 annotation
cpar
1 cpag
2
Number of gene models in original set
(all single-exon)
5822 5733
Unmodified in Cpar2 5195 4486
Modified in Cpar2
3 442 929
Removed in Cpar2 185 318
Additional gene models in Cpar2
3 173 395
1Annotation from Rossignol et al [18]
2Annotation from Butler et al [15]
3New and modified ORFs include the identification of 422 introns in 387
genes, listed in Additional file 4.
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Page 4 of 14introns present and 12 introns absent in D. hansenii
genes only, which may result from intron gain/loss.
However, we have not included this in Figure 3 because
we are lacking well-annotated sequence information
from close relatives of D. hansenii and so we cannot
determine when the gain/losses occurred.
We identified eight instances where introns were appar-
ently gained in C. parapsilosis, and 15 examples of
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Figure 2 Identification of introns. (A) Non strand-specific RNA-seq (data is from YPD media at 30°C) showing the expression level for gene
Cpar2_601470. Although expression of the 3’ UTR region is low, two potential introns were identified. The red arrows show the location of
oligonucleotide primers designed to confirm the presence of the introns. (B) Intron validation by PCR. Pairs of oligonucleotide primers flanking
the intronic region were used to amplify products from genomic DNA (D) or cDNA (R). Introns were confirmed in the 3’ UTR of Cpar2_601470,
the 5’ UTRs of Cpar2_400980 and Cpar2_205880, and within the coding sequence of 5 other genes (details of expected sizes are shown in
Additional file 8). The small bands in Cpar2_601830 and Cpar2_807560 are likely due to the presence of excess primers or to nonspecific
amplification.
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-13 +8 -15 +11 -22 +5 -4
-14
+6
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C. parapsilosis  -IPPTLWVKVKNLEPVSKRAIYLAGPYILYVDCRQLDYDPNVKYFVTADQPVFEPQLLP 94
C. albicans      -IPPTLWVKIRNTEPVSKRAIYLAGPYILYVDCRLLDYDPNVKYFVTADQPVFEPQLLA 101
C. dubliniensis  -IPPTLWVKIRNTEPVSKRAIYLAGPYILYVDCRLLDYDPNVKYFVTADQPVFEPQLLA 117
D. hansenii      KVPKSLWVKVKNIELIAFRAAYLAGPYVLYVDCKPEEYDPNKKCFITADQPVFEPQLLP 100
S. cerevisiae    LNLNSLWLKVRNMNPLSYRAAYLMGPFMLYCDVKTAQYHHSQKIVASVDYPKFEPNVQT 99
                     :**:*::* : :: ** ** **::** * :  :*. . * . :.* * ***:: .
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B
Figure 3 Analysis of intron gain and loss in Candida species. (A) 247 introns are conserved in four Candida species. We used S. cerevisiae
and other species as outgroups to try to identify introns that were lost or gained in specific lineages. Losses are indicated in red and gains in
green. Dh: D. hansenii; Cp: C. parapsilosis, Cd: C. dubliniensis, Ca: C. albicans. (B) Example of an intron gain in the C. parapsilosis ORF,
Cpar2_502430. This intron is not present in any of the other four species.
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Page 5 of 14intron loss (Additional file 7). Figure 3 shows one exam-
ple of intron gain. At least 6 of these introns are also
present in orthologs from C. orthopsilosis (Riccombeni
et al, in preparation), and were therefore most likely
gained in the common ancestor. We could not deter-
mine the presence of the remaining two in C. orthopsilo-
sis because of a lack of sequence information. In most
eukaryotes, intron loss is much more common than
intron gain [41-44]. However, intron gain is relatively
common in the Ascomycetes [37,45]. The molecular
mechanisms are still not known, and are hypothesized
to include insertion of transposable elements, insertion
of spliced introns from other genes into mRNA followed
by reverse transcription, and genomic duplication [41].
Intron loss is most likely to occur by reverse transcrip-
tion of spliced messenger mRNAs [41]. The origin of
the gained introns in C. parapsilosis is not clear; there
are no orthologous sequences elsewhere in the nuclear
or mitochondrial genome.
Identification of novel transcribed regions
Analysis of the transcriptional profile of C. albicans
using RNA-seq and microarrays has identified several
hundred, and possibly several thousand novel tran-
scribed regions (nTARs) that are unlikely to encode pro-
teins [29-31]. We manually examined the C. parapsilosis
data for evidence of nTARs. Because there is a wide
variety in the number of novel transcribed regions iden-
tified by different methods [29-31], we used a very con-
servative manual approach, and counted only those C.
parapsilosis regions where transcription is visually
higher than background. We identified 95 regions that
do not overlap with annotated ORFs (Additional file 8),
and do not appear to encode proteins. We suspect that
many of these regions may represent non-coding RNAs
or other regulatory RNAs. In fact, some are small
nuclear RNAs, such as the example shown in Figure 1C.
Analysis of the transcriptional response of C. parapsilosis
to hypoxia
Exposure of C. albicans to hypoxic conditions, such as
those encountered in the host during infection, results
i nas w i t c hf r o my e a s t - l i k et oh y p h a lg r o w t h ,i n c r e a s e d
expression of genes involved in ergosterol synthesis and
glycolysis, and decreased expression of genes encoding
steps in the TCA cycle and in oxidative phosphorylation
[46-51]. C. parapsilosis does not undergo true hyphal
growth. However, we previously used microarray profil-
ing to show that similar metabolic changes (i.e. increases
in glycolysis and ergosterol synthesis, decreases in
respiration) occur in cells exposed to low oxygen in
minimal media [18]. The transcriptional profile of cells
growing in hypoxia resembles that of biofilm cells for
both C. albicans and C. parapsilosis, and it has been
shown that the metabolic adaptation to hypoxia is
important for biofilm development by C. albicans
[18,52-54].
We describe here the use of RNA-seq and microarray
profiling to determine the transcriptional profile of C.
parapsilosis cells grown in rich medium in hypoxic con-
ditions. For the RNA-seq experiments, we observed a
high correlation among six biological replicates grown
in YPD in normoxia (1 > r > 0.95) and four biological
replicates grown in hypoxia (0.96 > r > 0.82) (Additional
file 9). Differentially expressed genes were identified by
using Cufflinks, open source software specifically design
to measure transcriptional differences [55]. Expression
values were defined using FPKM and quantile normali-
zation was applied.
A large number of genes are differentially expressed.
Most are up-regulated in hypoxic conditions (347 genes
up-regulated of 667 in total) (Additional file 10A). We
identified more genes with altered expression using
RNA-seq than by using microarrays [18] (667 versus
533, Additional file 10, Figure 4). However, although the
microarray and RNA-seq profiling experiments were
carried out at different times and by different personnel,
the correlation between the two approaches is high (r =
0.73) (Figure 4). For example, we observed a high degree
of overlap between the GO categories that are signifi-
cantly enriched using the two approaches (Additional
file 11). These include increased expression of genes
involved in carbohydrate metabolism and glycolysis,
fatty acid metabolism, and ergosterol biosynthesis, and
decreased expression of genes involved in cellular
respiration and the Tricarboxylic Acid Cycle (Additional
file 11). For up-regulated genes all of the GO processes
identified by microarray profiling are also present in the
RNA-seq data set; some additional categories were iden-
tified in the RNA-seq profile only, including fatty acid
oxidation and glucose transport (Additional file 11A).
For the down-regulated genes, some categories such as
amino-acid biosynthesis genes are over-represented in
the microarray profiling experiments, and purine meta-
bolism is over-represented in the RNA-seq data only.
Some of the differences observed may reflect differences
in experimental conditions; however, overall the two
approaches produced very similar results.
T h ec p a r 2 _ 4 0 4 8 5 0g e n eh a st h em o s td r a m a t i ci n c r e a s e
in expression in the RNA-seq (5- fold) and in the micro-
array profiling experiments (6.5-fold) (Additional file
10). Cpar2_404850 has no known ortholog in other
Candida species, no conserved domains, and no signifi-
cant similarity to any other known proteins. Expression
of cpar2_404850 is similar to that of the ergosterol path-
way genes (see discussion of cluster 3 below), and will
be the subject of future investigation. We have pre-
viously shown that RBT1 expression is increased during
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Page 6 of 14growth in minimal media in hypoxic conditions, and
that the gene is required for optimal biofilm formation
by C. parapsilosis [18]; our current analyses confirms
that hypoxic induction of RBT1 also occurs during
growth in rich media (Additional file 10).
In S. cerevisiae, expression of oxygen-responsive genes
in controlled by monitoring the levels of heme and
ergosterol [56-59]. Ergosterol synthesis genes are regu-
lated by the paralog pair ECM22 and UPC2,w h i c h
respond to sterol levels [60]. C. albicans has only one
ortholog of ECM22 and UPC2 (called UPC2), and this is
required for the up-regulation of ergosterol and drug
resistance genes in hypoxia [22,23,51,61]. We therefore
determined the effect of knocking out the ortholog of
UPC2 in C. parapsilosis. One allele was knocked out by
replacing HIS1, and one by replacing with URA3 (Addi-
tional file 12). Knocking out UPC2 increases the sensi-
tivity of C. parapsilosis cells to azole drugs (Figure 5),
similar to the phenotype reported for C. albicans
[23,61]. We used both microarrays and RNA-seq to
determine the transcriptional profile of wildtype and
upc2 deletion cells grown in hypoxic conditions. We
identified 116 genes that are differentially expressed in
the upc2 deletion grown using RNA-seq, and 103 genes
using microarray profiling (Additional file13A, B). The
same cell cultures were used for both experiments, and
there is a high correlation between the gene expression
levels identified by the two methods (r = 0.84, Figure
4B). 70 genes with differential expression were identified
by both methods (Additional file 13C). GO analysis indi-
cates that genes involved in ergosterol biosynthesis, lipid
biosynthesis and response to drug have decreased
expression in the upc2 deletion (Additional file 14).
To assess the importance of Upc2 as an hypoxic regula-
tor, we used hierarchical cluster analysis to identify
genes with shared expression patterns in the hypoxia/
normoxia dataset and in the upc2 deletion (Figure 5).
We used the profiles generated from microarrays rather
than RNA-seq for this comparison, partly because the
methods are better developed, and because it allowed us
to compare our results with our previously published
analysis of the hypoxic response of C. albicans [51]. We
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Figure 4 Comparison of RNA-seq and array profiling. (A) Correlation between the RNA-seq and microarray analysis for cells grown in rich
media in hypoxic conditions. (B) Correlation between the RNA-seq and microarray analysis for the comparison of the upc2 deletion and wildtype
cells grown in hypoxia. The log fold-changes of the FPKM ratio from the RNA-seq experiments is plotted on the x-axis, and the mean log fold-
change from the microarray analysis is plotted on the y-axis. Each circle corresponds to a single gene; genes that are significantly differentially
expressed in both microarray and RNA-seq analyses are colored in red.
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Figure 5 Analysis of the upc2 deletion in C. parapsilosis. (A) Wildtype and upc2 deletion strains of C. albicans and C. parapsilosis were grown
on YPD or YPD + 0.02 mg/ml ketoconazole plates for 5 days. Deleting UPC2 greatly increases the sensitivity of both species to ketoconazole.
Strains: C. albicans WT (SC5314), C. albicans upc2Δ (TW14920), C. parapsilosis WT (CLIB214), and two independent knockouts of upc2in C.
parapsilosis (CDupc5 and CDupc7). (B) Cluster analysis of genes differentially expressed in hypoxia and in the upc2 deletion of C. parapsilosis.
Details of the clusters are provided in Additional file 15. (C) Clusters 2, 3 and 4 from (B). The names of the C. albicans orthologs are given where
available. Where there is no ortholog, the cpar2 gene name is shown.
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15). Expression of genes in clusters 3 (5 genes) and 4
(25 genes) is greatly increased in wildtype cells grown in
hypoxia, and is repressed in the upc2 deletion grown in
the same conditions (Figure 5C). These clusters contain
most of the genes required for ergosterol metabolism.
Cluster 3 includes 3 genes encoding oxygen-dependent
enzymes (ERG3, ERG6 and ERG11)w h e r e a sc l u s t e r4
includes both oxygen-dependent (ERG1, ERG2, ERG4,
ERG5, ERG24, ERG25, ERG27) and oxygen-independent
steps (MVD, ERG9, ERG10, ERG13) (Figure 5C, Addi-
tional file 15). Genes in cluster 2 are also induced in the
wildtype in hypoxia, but not in the upc2 deletion. GO
analysis indicated that this cluster is enriched in pro-
cesses associated with glycolysis and carbohydrate meta-
bolism (Additional file 15B). Genes in cluster 1 are
induced in hypoxia in wildtype and in the upc2 deletion
(enriched in processes associated with oxidation-reduc-
tion), and genes in cluster 6 have reduced expression in
both strains (enriched in processes associated with the
TCA cycle, cellular respiration and ATP synthesis).
Genes in cluster 5 are more upregulated in hypoxia in
the upc2 deletion, and are not enriched for any specific
GO processes
Our results suggest that Upc2 in C. parapsilosis is
required for induction of expression of ergosterol synth-
esis genes in hypoxia (clusters 3 and 4). In the absence
of UPC2, expression of these genes is repressed. Delet-
ing UPC2 decreases the hypoxic induction of glycolytic
g e n e s( c l u s t e r2 ) ,b u tn o tt oa sg r e a ta ne x t e n ta st h e
reduction in expression of the ergosterol pathway. It is
therefore likely that similar to C. albicans, expression of
the ergosterol pathway in C. parapsilosis is directly
regulated by Upc2, but expression of glycolytic genes
although influenced by Upc2 is likely to be controlled
by other transcription factors (such as Gal4 and Tye7,
as in C. albicans [46]). Upc2 does not play any role in
the reduction of expression of respiratory genes in
hypoxia (cluster 6) nor in the induction of genes asso-
ciated with oxidation-reduction (cluster 1). The poten-
tial role of Upc2 to regulate genes in cluster 5 requires
further investigation.
We did not observe a statistically significant enrich-
ment of iron metabolism genes during hypoxic growth
of C. parapsilosis, in either the microarray or the RNA-
seq data. This differs from C. albicans [51]. However,
expression of at least three ferric reductases (FRE10,
FRP1 and CFL5), an iron permease (FTR1), a multicop-
per oxidase and several iron-containing proteins is
decreased, and expression of HEM13,h e m eo x y g e n a s e
(HMX1) and a catalase (CAT1) is increased in the RNA-
seq data, and for some also in the microarray data
(Additional file 10). It is therefore likely that iron
metabolism genes are similarly regulated in the two spe-
cies. Overall, our analyses indicate that C. albicans and
C. parapsilosis have a similar response to hypoxia, and
that the role of Upc2 is conserved.
Conclusions
We describe the first comprehensive annotation of the
C. parapsilosis genome, which is supported by expres-
sion analysis. We identified > 300 new open reading
frames and corrected the annotation of hundreds more.
We also identified several nTARs, many of which are
likely to represent non-coding RNAs (ncRNA). We
identified two introns in the 3’ UTR of a single gene,
suggesting that regulated splicing may be involved in
gene regulation. C. parapsilosis genes have few introns,
similar to other species in the Saccharomycotina. How-
ever, we identified a small number of introns that were
both gained and lost in recent evolutionary history. We
also used RNA-seq and microarray profiling to identify
the targets of the Upc2 transcription factor, and show
that it has a major role as a regulator of ergosterol
synthesis in C. parapsilosis.
Methods
Assembly
The C. parapsilosis genome was originally assembled as
described in Butler et al [15] and submitted to EMBL as
24 contigs (CABE01000001-CABE01000024). Some
errors and gaps have now been manually corrected, and
the genome has now been assembled into 8 chromo-
some-sized contigs larger than 200 kb (version 012609).
We have re-named the major contigs as chromosomes 1
(contig005569), 2 (contig005809), 3 (contig005806), 4
(contig006372), 5 (contig006139), 6 (contig005504), 7
(contig006110) and 8 (contig005807). The mitochondrial
genome is represented by contig006121. The assembly
has replaced the original submission, and is available at
accession numbers HE605202-HE605210.
Strains and Media
The strains used in this study are listed in Additional file
16. Oligonucleotide primers used in RT-PCR and to vali-
date constructs and introns are listed in Additional file
17. Cells were grown in YPD (1% Yeast Extract, 2% Pep-
tone, 2% Glucose; FormediumTM), YPGlycerol (YPD
with 2% glycerol instead of 2% glucose), BMW (1.5%
Y e a s tE x t r a c t ,1 %P e p t o n e ,2 %G l u c o s e ,0 . 2 %S CA m i n o
Acid mix, 0.01% Adenine, 0.01% Tryptophan, 0.01% Ura-
cil; [62,63]) and synthetic defined (SD) media (0.676%
Yeast Nitrogen Base without amino acids, 2% Glucose).
Cells were grown at 30°C and 21% O2 unless otherwise
noted. Where indicated, cells were grown in 1% oxygen,
99% nitrogen in an InVivo2 400 hypoxic chamber.
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Both alleles of UPC2 were knocked out by replacement
with URA3 and HIS1 in C. parapsilosis CDUhis11
(Additional file 12). The URA3 or HIS1 disruption cas-
settes were generated from plasmid pLUL2 or pLHL2
[64], respectively using oligonucleotides, UPCUH_F and
UPCUH_R (Additional file 17).
RNA isolation
The cells were harvested by centrifugation and either
subjected to RNA extraction or frozen at -80°C. Total
RNA was extracted from fresh or frozen cell pellets
using a RiboPure Yeast Kit (Ambion). RNA concentra-
tions were determined using a NanoDrop 1000 (Thermo
Scientific), while quality and integrity was checked using
a Bioanalyzer 2100 (Agilent Technologies).
Microarray analysis
The hypoxia experiments in rich media were carried out
at the same time as our previous analysis of the hypoxic
response in minimal media [18]. However the results
w e r en o tr e p o r t e dp r e v i o u s l y .O v e r n i g h tc u l t u r e so fC.
parapsilosis CLIB214 were subcultured in 300 ml YPD
at an A600 of 0.2. The culture was maintained at 30°C
for 3 h at atmospheric oxygen conditions. Two aliquots
were then removed after 3 h cell growth; one culture
was incubated at atmospheric oxygen conditions, and
the other was incubated in 1% O2 for an additional 3 h.
RNA was isolated and cDNA generated and labeled
with Cy3 or Cy5 as described in Rossignol et al [18].
Four biological replicates were compared: in all four the
normoxic samples were labeled with Cy3 and the
hypoxic samples were labeled with Cy5. To determine
the transcriptional profile of the upc2 deletion, C. para-
psilosis CLIB214 (wildtype) and C. parapsilosis CDupc5
(upc2 deletion) cells were grown in YPD at atmospheric
oxygen for 3.5 h and then transferred to 1% O2 for an
additional 2 h. Four biological replicates were used: in
the first two, RNA from the wildtype strain was labeled
with Cy3 and the upc2 deletion was labeled with Cy5.
cDNA was generated, labeled, and hybridized to C.
parapsilosis microarrays designed and manufactured
using eArray from Agilent as described in Rossignol et
al [18]. The microarray platform is described on the
NCBI Gene Expression Omnibus Database (GEO), with
the ID GPL13192. Data were analyzed using the Limma
package [65] from Bioconductor http://bioconductor.org
as described in [18,51]. Only genes with a fold change
(FC) greater than 2 and an adjusted p-value less than
0.05 were considered.
GO enrichment analysis
All the GO term enrichment analyses were performed
using the web application “GO term finder” available on
the “Candida Genome Database” (CGD, http://www.can-
didagenome.org/cgi-bin/GO/goTermFinder). When test-
ing C. parapsilosis gene lists, the C. albicans orthologs
extracted from the Candida Gene Order Browser [19]
CGOB were used, and the background for the test was
appropriately adjusted by excluding those C. albicans
genes found not to have a C. parapsilosis ortholog.
RNA-seq library preparation
Cells were grown at 30°C overnight and then diluted to
an A600 of 0.2, and grown for an additional 5 h at 30°C
or 37°C in YPD, BMW, YPglycerol or SD media in
either 21% or 1% O2 (Additional file 1). mRNA purified
from total RNA using oligo dT Dynabeads (Invitrogen)
was fragmented to an average size of 200 nucleotides by
a 5 minute heat treatment (70°C) with a buffered zinc
solution (Fragmentation Reagent, Ambion). Fragmenta-
tion of mRNA was stopped using an EDTA based Stop
buffer (Ambion). Fragmented mRNA was incubated
with 3 μg Random Hexamer Primers at 65°C for 5 min.
First strand cDNA synthesis was carried out using 1 ×
First Strand Buffer (Invitrogen), 10 mM DTT, 500 μM
dNTP mix (Invitrogen), 20 Units RNaseOUT and 200
units SuperScript™ II Reverse Transcriptase (Invitro-
gen). For strand-specific library generation, unincorpo-
rated dNTPs were subsequently removed using G-50
Micro Columns (GE Healthcare). Second strand cDNA
was generated using 1× Second Strand Buffer, 300 μM
dNTP mix, 2 units RNaseH, 50 units DNA Polymerase I
(NEB), while a 300 μM dUTP mix was used instead of a
dNTP mix for the generation of a strand specific library.
This material was used for library preparation. The
method for strand-specific library preparation was
adapted from Parkhomchuk et al [66] as described in
Weissenmayer et al [ 6 7 ] .B r i e f l y ,D N Af r a g m e n t sw e r e
blunted in an End Repair reaction using T4 DNA Poly-
merase, Klenow DNA Polymerase and T4 Polynucleo-
tide Kinase, after which a single ‘A’ base was added to
the 3’ end using dATP and Klenow Exo Fragment. Illu-
mina adapters were ligated to the ends of the DNA frag-
ments, allowing for the subsequent hybridization to a
flow cell. Fragments of approximately 300 base pairs
were purified from a 2% Agarose Gel. For the strand-
specific libraries, the second strand containing uridine
was removed by treatment with 1 unit Uracil N-glycosy-
lase (UNG) in TE Buffer at 37°C for 15 min. In all
cases, purified adapter ligated DNA templates were then
amplified through PCR enrichment, using PCR primers
(Illumina), a dNTP mix, Phusion Polymerase (NEB) and
16 cycles of PCR. All libraries were quantified using a
Qubit Fluorometer (Invitrogen) and assessed on a 2%
agarose gel. Amplified libraries were loaded on a flow
cell. Sequencing was carried out in-house by running at
least 36 cycles on an Illumina Genome Analyzer IIx
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read lengths of approximately 42 bases. In addition, long
reads (76 bases) were generated from two libraries by
GATC Biotech AG using an Illumina Genome Analyzer
IIx (Additional file 1).
Read mapping and expression analysis
In-house reads were processed according to version 1.4
of Illumina’s Genome Analysis Pipeline. FastQ files were
preprocessed by customized scripts designed to control
data quality and to detect the presence of adapter
sequences (data not shown). Reads from each dataset
were aligned to the 8 C. parapsilosis chromosomal con-
tigs using TopHat [25]. To minimize mapping errors
and address the issue of repetitive regions, reads which
mapped to more than one location or with more than 2
alignment mis-matches were discarded. TopHat was
first set to detect introns with length not lower than 70
nucleotides and, secondly with length not lower than 10
nucleotides. The results were handled using SAMtools,
a package of computational tools for next generation
sequencing format manipulation [68]. Reads that
mapped to the genome through a gapped alignment
were identified and isolated. Each candidate was manu-
ally curated and discarded where necessary. Data were
visualized using the Artemis genome browser [26] and
Tablet, a next generation sequence assembly visualiza-
tion tool [69].
The RNA-seq data was combined with the existing
cpag and cpar annotations [15,18] and mapped onto the
8 chromosome contigs. Genes are named using the pre-
fix “Cpar2”. Gene models are numbered using a six-digit
number; the first digit specifies the chromosome. 91
Putative tRNA genes were identified and were incorpo-
rated into the annotation using tRNAscan-SE [27].
We applied CuffDiff from the package Cufflinks [55]
to identify differentially expressed genes. Cufflinks
measures FPKM (fragments per kilobase of transcript
per million fragments mapped); the results of the dif-
ferential expression test are reported as log ratios of
the FPKM values. CuffDiff incorporates data from bio-
logical repeats (listed in additional File 1). We used 4
biological replicates grown in hypoxic condition and 5
biological replicates from normoxic conditions
(libraries generated with longer reads and technical
replicates where not included); and 4 biological repli-
cates from wildtype and 2 biological replicates from a
upc2 deletion grown in hypoxic conditions. Quantile-
based normalization was used to identify differentially
expressed genes [70]. Genes with a p-value of < 0.05
were considered to be differentially expressed. A Ben-
jamini-Hochberg [71] correction for multiple-testing
was also applied and genes with p-value greater then
the FDR were discarded.
Some minor annotation changes were made to the
genome after most of the analyses (expression analysis,
UTR identification etc.) were carried out. The most up-
to-date annotation was submitted to EMBL, and is
included in Table 1.
UTR detection
To identify the 5’ and 3’ UTR boundaries of protein-cod-
ing genes, we scanned the RNA-seq coverage from each
experimental condition. The coverage upstream from the
ATG and downstream from the stop codon of each
annotated ORF was examined by an in-house program
which counted the number of reads mapped at each
coordinate. The longest continuous signal with at least 2
reads at each coordinate was considered. If the signal
extended as far as reaching the boundary of the adjacent
gene in at least one experiment, the region was consid-
ered to be “overlapping” and therefore impossible to
resolve. Strand-specific data were used to map the UTRs
of genes transcribed from different strands. Regions with
low expression or with lack of RNA-seq evidence were
discarded and marked with “no coverage”. A special tag
was added to those genes near the edges of the contig; in
cases where the UTR signal extended to the last or first
coordinate the regions was annotated as “reached end of
the contig”. Genes with introns in the 5’ and 3’ regions
were manually corrected (Additional file 5).
nTAR identification
nTARs (novel transcriptional active regions) were identi-
fied during the manual curation of the genome. The
overall expression was visualized with the Artemis gen-
ome annotation browser [26] for each biological condi-
tion. Whenever it was not possible to identify an open
reading frame, or where any potential ORFs were < 100
amino acids and not conserved in other Candida spe-
cies, we marked the location as a possible nTAR.
Intron loss/gain analysis
Orthologous groups of genes from four species (C. albi-
cans, C. dubliniensis, C. parapsilosis and D. hansenii)
were identified using CGOB (Maguire et al,i np r e p a r a -
tion) [19]. Genes containing at least one intron in one
species were identified. The orthologous proteins were
aligned using T-Coffee [72]. A PERL script was written
to identify introns conserved in 2 or more species,
defined as being within 10 amino acids in the multiple
sequence alignment. Where possible, orthologous genes
were identified in outgroup species including S. cerevi-
siae, Pichia pastoris, Lachancea kluyveri and Eremothe-
cium gossypii. Intron gain/loss was determined by
manual inspection (Additional file 7). For example,
introns present in C. albicans and C. dubliniensis only
were assumed to be gained on this branch, rather than
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Page 11 of 14lost in all other species. For several cases it was not pos-
sible to determine if specific introns were gained or lost.
We noticed that one gene in C. dubliniensis
(CD36_81540) and one in D. hansenii (DEHA2G18062g)
contain putative introns that are not in the published
annotations.
Accession codes and Supplementary Websites
R a wm i c r o a r r a yd a t aa n dt h ed e s c r i p t i o no ft h ea r r a y
have been deposited in the Gene Expression Omnibus
Database, under the series number GSE32716. The
annotation is available from EMBL (accession no
HE605202-HE605210).
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